President/Ceo, Consulting Firm
Current• Partnered with VCs, investment firms, & family offices provide diligence: competitive intelligence, market analysis, comprehensive technical & clinical assessments, develop milestones, regulatory strategy, & roadmaps for company & lab buildouts on acquisition/investment of high priority assets, companies, technologies, and platforms. • Provide technical, operational, regulatory, & clinical strategy to a diverse array of clients including biotech (early-stage, pre-clinical-phase III), device companies, analytical service providers, & diagnostic companies.• Implement strategy for successful execution and launch of products (including phase I-III trials) and partnerships, including co-development and launch of diagnostics, therapeutics, & medical devices.• Advance first-in-class therapies and devices towards therapeutic & commercial success, extend run ways, de-risk investments yet increase investment opportunities for Research Academic Centers, KOLs, Accelerators/Incubators, & Startups through fast-track evaluations & prioritization of programs, developing competitive Go-to-Market Strategies, and robust, global partnerships & research agreements.
